Almac, a global service provider based in Ireland, has further enhanced its service offering with the completed expansion of refrigerated (2-8°C) storage and newly developed refrigerated labelling facilities at its U.K. site.
This enhancement doubles Almac’s refrigerated storage capacity at its U.K. site and comes as a response to a growing number of client requests involving biologics, biosimilar compounds and other temperature critical material.
With the introduction of the refrigerated labeling facility and expansion of refrigerated storage, Almac is able to offer a more streamlined cold chain service by ensuring the material flow is consistently monitored at every stage in the clinical supply chain. The offering, mirrored at the company’s U.S. headquarters in Souderton, Penn., is a substantial benefit to existing and potential clients where maintaining temperature control is critical to the shelf life and stability of their compound or the chosen comparator.
“Our suite of leading cold chain solutions is a response to the growing customer demand for clinical services for temperature sensitive materials,” said Martin Lamb, vice president of business development, Almac. “Our goal is to provide closed loop cold-chain solutions tailored towards our customer’s individual needs, remaining mindful that we are servicing an industry wherein effectiveness and efficiency are increasingly sought after attributes.”